|
|
||||||||
transgenic mice
1Departments of Pharmacology and Pediatrics, University of Alberta, Edmonton, Alberta, Canada T6G 2S2; and 2Division of General and Developmental Medicine, Department of Diabetes and Metabolic Medicine, St. Bartholomew's and the Royal London School of Medicine and Dentistry, Queen Mary, University of London, London, E1 4NS United Kingdom
Submitted 30 September 2002 ; accepted in final form 14 March 2003
The pyruvate dehydrogenase enzyme complex (PDC) is rate limiting for
glucose oxidation in the heart. Inhibition of PDC by end-product feedback and
phosphorylation by pyruvate dehydrogenase kinase (PDK) operate in concert to
inhibit PDC activity. Because the transcriptional regulator peroxisome
proliferator-activated receptor (PPAR)-
increases PDK expression in
some tissues, we examined what role PPAR-
has in regulating glucose
oxidation in hearts from mice overexpressing PPAR-
(MHC-PPAR-
mice). Glucose oxidation rates were decreased in isolated working hearts from
MHC-PPAR-
mice compared with wild-type littermates (428 ± 113
vs. 771 ± 63 nmol · g dry weight-1
· min-1, respectively), which was accompanied by
a parallel increase in fatty acid oxidation. However, there was no difference
in PDC activity between MHC-PPAR-
and wild-type animals, even though
the expression of the PDK isoform PDK1 was increased in MHC-PPAR-
mice.
Glucose oxidation rates in both MHC-PPAR-
and wild-type mouse hearts
were decreased after 48-h fasting (which increases PPAR-
expression) or
by treatment of mice with the PPAR-
agonist WY-14,643 for 1 wk. Despite
this, PDC activity in both animal groups was not altered. Taken together,
these data suggest that glucose oxidation rates in the heart can be
dramatically altered independent of PDK phosphorylation and inhibition of PDC
by PDK. It also suggests that PPAR-
activation decreases glucose
oxidation in hearts mainly by decreasing the flux of pyruvate through PDC due
to negative feedback of PDC by fatty acid oxidation reaction products rather
than by the phosphorylated state of the PDC complex.
glucose oxidation; fatty acid oxidation; pyruvate dehydrogenase kinase
This article has been cited by other articles:
![]() |
N. Sambandam, D. Morabito, C. Wagg, B. N. Finck, D. P. Kelly, and G. D. Lopaschuk Chronic activation of PPAR{alpha} is detrimental to cardiac recovery after ischemia Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H87 - H95. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Dewald, S. Sharma, J. Adrogue, R. Salazar, G. D. Duerr, J. D. Crapo, M. L. Entman, and H. Taegtmeyer Downregulation of Peroxisome Proliferator-Activated Receptor-{alpha} Gene Expression in a Mouse Model of Ischemic Cardiomyopathy Is Dependent on Reactive Oxygen Species and Prevents Lipotoxicity Circulation, July 19, 2005; 112(3): 407 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Huss and D. P. Kelly Nuclear Receptor Signaling and Cardiac Energetics Circ. Res., September 17, 2004; 95(6): 568 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Stanley Myocardial Energy Metabolism During Ischemia and the Mechanisms of Metabolic Therapies Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S31 - S45. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |